Indical Bioscience, part of the Vimian group, enters strategic partnership with pioneering air sampling technology company

News
Aug 23 2021

Indical Bioscience, part of the Vimian group, enters strategic partnership with pioneering air sampling technology company

Indical Bioscience, the operating company within Vimian’s Diagnostics segment, has signed a global development and distribution agreement with AeroCollect. AeroCollect is a Danish company specializing in air sampling technology for the early detection of pathogens in veterinary diagnostics. The partnership is expanding Vimian’s offering within the producer and food safety market.

AeroCollect is a fully owned subsidiary of the Danish government-approved Research and Technology Organisation FORCE Technology, which developed the air sampling technology. The technology has shown great potential in recent years and is currently used in the poultry, swine and mink industries and today has over 60 customers in 14 countries.

Through the partnership Indical Bioscience will take charge of global sales and distribution leveraging the current commercial network and jointly continue to leverage the technology into new applications and solutions for other segments.

“The partnership with AeroCollect will expand our portfolio in the producer and food safety market segments and can be leveraged to develop solutions for other segments. The pioneering technology will facilitate easier, faster and more accurate sampling in vet diagnostics to support our ambition to improve animal health globally”, says Stefano Santarelli, CEO of Indical Bioscience.

AeroCollect® works by pulling a flow of air through a small sample chamber. When collecting samples, high voltage is applied to the test chamber. This creates an electric field across the sample chamber that captures and concentrates bacteria, viruses, and other microscopic particles in the sample chamber. The sample chamber is then sent to the laboratory where the content is analysed for pathogens using a qPCR analysis. The results are ready within one to two hours.

Indical Bioscience, the operating company within Vimian’s Diagnostics segment, is a global leader in the development of complete solutions for molecular and immunological veterinary testing to identify, prevent, monitor, and eradicate animal diseases. The offering is suited to both the livestock and companion animal health markets. The products and workflows for veterinary diagnostics and pathogen research are trusted by lab technicians, vets, and organizations worldwide, including government agencies, laboratories, research institutes, farmers, and producers.

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 400 people and have a combined annual turnover of approximately EUR 140 million. For more information, please visit: www.vimian.com.